arrow_back Back to App

Supporting Glioblastoma Awareness Day

The U.S. House of Representatives supports designating July 19, 2023, as Glioblastoma Awareness Day. This aims to increase public understanding of this aggressive disease, honor patients and their families, and encourage further research into new treatments. Citizens may benefit from greater public awareness and potentially improved access to information about support and research.
Key points
The establishment of Glioblastoma Awareness Day aims to increase public knowledge about this disease, which is the most common and aggressive brain tumor.
The initiative seeks to honor individuals affected by glioblastoma and their caregivers, while also emphasizing the need for continued investment in research for new, more effective treatments.
It supports the development of biomarker testing, crucial for diagnosis and treatment, and encourages collaboration among organizations to accelerate progress in combating the disease.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_425
Sponsor: Rep. Mast, Brian J. [R-FL-21]
Process start date: 2023-05-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Supporting the designation of July 19, 2023, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_425.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-18.

What are the main provisions?

Key points include:

  • The establishment of Glioblastoma Awareness Day aims to increase public knowledge about this disease, which is the most common and aggressive brain tumor.
  • The initiative seeks to honor individuals affected by glioblastoma and their caregivers, while also emphasizing the need for continued investment in research for new, more effective treatments.
  • It supports the development of biomarker testing, crucial for diagnosis and treatment, and encourages collaboration among organizations to accelerate progress in combating the disease.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Mast, Brian J. [R-FL-21].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health